Redox regulation in malaria: Current Concepts and pharmacotherapeutic implications

Current Medicinal Chemistry

Volumn 19, Issue 10, 2012, Pages 1475-1503

  Goyal, M ^a   Alam, A ^a   Bandyopadhyay, U ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Antimalarial; Dithiols; Free heme; Hemozoin; Reactive oxygen species; Redox active

Indexed keywords

1,4 NAPHTHOQUINONE; AMODIAQUINE; AMOPYROQUINE; ARTEMISININ; ARTESUNATE; AZURE B; BENFLUMETOL; CARMUSTINE; CHLOROQUINE; CURCUMIN; ELLAGIC ACID; GLUTAREDOXIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HEMATOPORPHYRIN; HYDROXYPIPERAQUINE; MEFLOQUINE; MEPACRINE; METHYLENE BLUE; PIPERAQUINE; PYOCYANINE; PYRIMETHAMINE; PYRONARIDINE; QUINIDINE; QUININE; SUPEROXIDE DISMUTASE; TEBUQUINE; THIONINE; TOLONIUM CHLORIDE; UNINDEXED DRUG;

ANTIMALARIAL ACTIVITY; APICOPLAST; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; ENDOPLASMIC RETICULUM; HUMAN; MALARIA; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; UNINDEXED SEQUENCE;

ANTIMALARIALS; ENZYME INHIBITORS; GLUTATHIONE; HUMANS; MALARIA; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOREDUCTASES; REACTIVE OXYGEN SPECIES; THIOREDOXINS;

EID: 84858768957     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799828328     Document Type: Review

References (208)

1. Breman, J.G.; Alilio, M.S.; Mills, A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg., 2004, 71, (2 Suppl), 1-15. (Pubitemid 39127486)
2. Gardner, M.J.; Hall, N.; Fung, E.; White, O.; Berriman, M.; Hyman, R.W.; Carlton, J.M.; Pain, A.; Nelson, K.E.; Bowman, S.; Paulsen, I.T.; James, K.; Eisen, J.A.; Rutherford, K.; Salzberg, S.L.; Craig, A.; Kyes, S.; Chan, M.S.; Nene, V.; Shallom, S.J.; Suh, B.; Peterson, J.; Angiuoli, S.; Pertea, M.; Allen, J.; Selengut, J.; Haft, D.; Mather, M.W.; Vaidya, A.B.; Martin, D.M.; Fairlamb, A.H.; Fraunholz, M.J.; Roos, D.S.; Ralph, S.A.; McFadden, G.I.; Cummings, L.M.; Subramanian, G.M.; Mungall, C.; Venter, J.C.; Carucci, D.J.; Hoffman, S.L.; Newbold, C.; Davis, R.W.; Fraser, C.M.; Barrell, B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature, 2002, 419, (6906), 498-511.
3. Miller, L.H.; Baruch, D.I.; Marsh, K.; Doumbo, O.K. The pathogenic basis of malaria. Nature, 2002, 415, (6872), 673-679. (Pubitemid 34136400)
4. Dey, S.; Guha, M.; Alam, A.; Goyal, M.; Bindu, S.; Pal, C.; Maity, P.; Mitra, K.; Bandyopadhyay, U. Malarial infection develops mitochondrial pathology and mitochondrial oxidative stress to promote hepatocyte apoptosis. Free. Radic. Biol. Med., 2009, 46, (2), 271-281.
5. Guha, M.; Kumar, S.; Choubey, V.; Maity, P.; Bandyopadhyay, U. Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FASEB. J., 2006, 20, (8), 1224-1226.
6. Guha, M.; Maity, P.; Choubey, V.; Mitra, K.; Reiter, R.J.; Bandyopadhyay, U. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J. Pineal. Res., 2007, 43, (4), 372-381. (Pubitemid 47512269)
7. Linares, G.E.; Rodriguez, J.B. Current status and progresses made in malaria chemotherapy. Curr. Med. Chem., 2007, 14, (3), 289-314.
8. White, N.J. Antimalarial drug resistance. J. Clin. Invest., 2004, 113, (8), 1084-1092. (Pubitemid 38544090)
9. Alam, A.; Goyal, M.; Iqbal, M.S.; Pal, C.; Dey, S.; Bindu, S.; Maity, P.; Bandyopadhyay, U. Novel antimalarial drug targets: hope for new antimalarial drugs. Expert. Rev. Clin. Pharmacol., 2009, 2, (5), 469-489.
10. Pal, C.; Bandyopadhyay, U. Redox-active antiparasitic drugs. Antioxid. Redox. Signal., 2011, in press.
11. Oliveira, P.L.; Oliveira, M.F. Vampires, Pasteur and reactive oxygen species. Is the switch from aerobic to anaerobic metabolism a preventive antioxidant defence in blood-feeding parasites? FEBS. Lett., 2002, 525, (1-3), 3-6.
12. Becker, K.; Tilley, L.; Vennerstrom, J.L.; Roberts, D.; Rogerson, S.; Ginsburg, H. Oxidative stress in malaria parasite-infected erythrocytes: hostparasite interactions. Int. J.Parasitol., 2004, 34, (2), 163-189. (Pubitemid 38229822)
13. Hunt, N.H.; Stocker, R. Oxidative stress and the redox status of malariainfected erythrocytes. Blood Cells, 1990, 16, (2-3), 499-526.
14. Krungkrai, J. Malarial dihydroorotate dehydrogenase mediates superoxide radical production. Biochem. Int., 1991, 24, (5), 833-839.
15. Bandyopadhyay, U.; Dey, S. In. Apicomplexan Parasites: Molecular Approaches Toward Targeted Drug Development; Katza Becker, Ed. Wiley-Blackwell.V:Weinheim, 2011; Vol. 2, pp. 205-234.
16. Kannan, R.; Kumar, K.; Sahal, D.; Kukreti, S.; Chauhan, V.S. Reaction of artemisinin with haemoglobin: implications for antimalarial activity. Biochem. J., 2005, 385, (Pt 2), 409-418. (Pubitemid 40165073)
17. Kumar, S.; Bandyopadhyay, U. Free heme toxicity and its detoxification systems in human. Toxicol. Lett., 2005, 157, (3), 175-188. (Pubitemid 40726102)
18. Kumar, S.; Guha, M.; Choubey, V.; Maity, P.; Bandyopadhyay, U. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life. Sci., 2007, 80, (9), 813-828. (Pubitemid 46149853)
19. Brunet, L.R. Nitric oxide in parasitic infections. Int. Immunopharmacol., 2001, 1, (8), 1457-1467. (Pubitemid 32622790)
20. Bull, P.C.; Lowe, B.S.; Kortok, M.; Molyneux, C.S.; Newbold, C.I.; Marsh, K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med., 1998, 4, (3), 358-360. (Pubitemid 28144099)
21. Descamps-Latscha, B.; Lunel-Fabiani, F.; Kara-Binis, A.; Druilhe, P. Generation of reactive oxygen species in whole blood from patients with acute falciparum malaria. Parasite Immunol., 1987, 9, (2), 275-279. (Pubitemid 17045762)
22. Golenser, J.; Chevion, M. Oxidant stress and malaria: host-parasite interrelationships in normal and abnormal erythrocytes. Semin. Hematol., 1989, 26, (4), 313-325. (Pubitemid 19271291)
23. Kharazmi, A.; Jepsen, S.; Andersen, B.J. Generation of reactive oxygen radicals by human phagocytic cells activated by Plasmodium falciparum. Scand. J. Immunol., 1987, 25, (4), 335-341.
24. Deponte, M.; Becker, K.; Rahlfs, S. Plasmodium falciparum glutaredoxinlike proteins. Biol. Chem., 2005, 386, (1), 33-40.
25. Muller, S. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol. Microbiol., 2004, 53, (5), 1291-1305. (Pubitemid 39209105)
26. Nickel, C.; Rahlfs, S.; Deponte, M.; Koncarevic, S.; Becker, K. Thioredoxin networks in the malarial parasite Plasmodium falciparum. Antioxid. Redox. Signal., 2006, 8, (7-8), 1227-1239. (Pubitemid 44182421)
27. Gunther, S.; Storm, J.; Muller, S. Plasmodium falciparum: organelle-specific acquisition of lipoic acid. Int. J. Biochem. Cell. Biol., 2009, 41, (4), 748-752.
28. Urscher, M.; Przyborski, J.M.; Imoto, M.; Deponte, M. Distinct subcellular localization in the cytosol and apicoplast, unexpected dimerization and inhibition of Plasmodium falciparum glyoxalases. Mol. Microbiol., 2010, 76, (1), 92-103.
29. Jortzik, E.; Mailu, B.M.; Preuss, J.; Fischer, M.; Bode, L.; Rahlfs, S.; Becker, K. Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparum. Biochem. J., 2011, 436, (3), 641-650.
30. Li, Y.; Ning, Y.S.; Dong, W.Q.; Li, M. [Soluble expression of Plasmodium falciparum glutamate dehydrogenase in Escherichia coli, and its purification and identification]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za. Zhi., 2004, 22, (2), 94-97.
31. Wrenger, C.; Muller, S. Isocitrate dehydrogenase of Plasmodium falciparum. Eur. J. Biochem., 2003, 270, (8), 1775-1783.
32. Elliott, D.A.; McIntosh, M.T.; Hosgood, H.D. 3rd; Chen, S.; Zhang, G.; Baevova, P.; Joiner, K.A. Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 2008, 105, (7), 2463-2468. (Pubitemid 351520536)
33. Francis, S.E.; Sullivan, D.J. Jr.; Goldberg, D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol., 1997, 51, 97-123. (Pubitemid 27433044)
34. Golenser, J.; Marva, E.; Har-El, R.; Chevion, M. Induction of oxidant stress by iron available in advanced forms of Plasmodium falciparum. Free. Radic. Res. Commun., 1991, 12-13, 639-643.
35. Ginsburg, H.; Famin, O.; Zhang, J.; Krugliak, M. Inhibition of glutathionedependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem. Pharmacol., 1998, 56, (10), 1305-1313. (Pubitemid 28511267)
36. Solar, I.; Dulitzky, J.; Shaklai, N. Hemin-promoted peroxidation of red cell cytoskeletal proteins. Arch. Biochem. Biophys., 1990, 283, (1), 81-89. (Pubitemid 20380649)
37. Gluzman, I.Y.; Francis, S.E.; Oksman, A.; Smith, C.E.; Duffin, K.L.; Goldberg, D.E. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest., 1994, 93, (4), 1602-1608. (Pubitemid 24116398)
38. Vander Jagt, D.L.; Hunsaker, L.A.; Campos, N.M. Comparison of proteases from chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum. Biochem. Pharmacol., 1987, 36, (19), 3285-3291. (Pubitemid 17161018)
39. Campanale, N.; Nickel, C.; Daubenberger, C.A.; Wehlan, D.A.; Gorman, J.J.; Klonis, N.; Becker, K.; Tilley, L. Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum. J .Biol. Chem., 2003, 278, (30), 27354-27361. (Pubitemid 36899916)
40. Famin, O.; Ginsburg, H. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase. Parasite., 2003, 10, (1), 39-50. (Pubitemid 37363201)
41. Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol., 2003, 552, (Pt 2), 335-344. (Pubitemid 37321833)
42. Fisher, N.; Bray, P.G.; Ward, S.A.; Biagini, G.A. The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle. Trends. Parasito.l, 2007, 23, (7), 305-310. (Pubitemid 46935569)
43. Segura, C.; Blair, S. La mitocondria en el género Plasmodium. Biomedica., 2003, 23, (3), 351-363.
44. Coban, C.; Yagi, M.; Ohata, K.; Igari, Y.; Tsukui, T.; Horii, T.; Ishii, K.J.; Akira, S. The malarial metabolite hemozoin and its potential use as a vaccine adjuvant. Allergol. Int., 2010, 59, (2), 115-124.
45. Underhill, D.M.; Ozinsky, A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol., 2002, 20, 825-852. (Pubitemid 34293441)
46. Golenser, J.; Kamyl, M.; Tsafack, A.; Marva, E.; Cohen, A.; Kitrossky, N.; Chevion, M. Correlation between destruction of malarial parasites by polymorphonuclear leucocytes and oxidative stress. Free. Radic. Res. Commun., 1992, 17, (4), 249-262.
47. Casares, S.; Richie, T.L. Immune evasion by malaria parasites: a challenge for vaccine development. Curr. Opin. Immunol., 2009, 21, (3), 321-330.
48. Kumar, S.; Christophides, G.K.; Cantera, R.; Charles, B.; Han, Y.S.; Meister, S.; Dimopoulos, G.; Kafatos, F.C.; Barillas-Mury, C. The role of reactive oxygen species on Plasmodium melanotic encapsulation in Anopheles gambiae. Proc. Natl. Acad. Sci. USA, 2003, 100, (24), 14139-14144. (Pubitemid 37499204)
49. Maines, M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB. J., 1988, 2, (10), 2557-2568.
50. Egan, T.J. Haemozoin formation. Mol. Biochem. Parasitol., 2008, 157, (2), 127-136.
51. Egan, T.J.; Combrinck, J.M.; Egan, J.; Hearne, G.R.; Marques, H.M.; Ntenteni, S.; Sewell, B.T.; Smith, P.J.; Taylor, D.; van Schalkwyk, D.A.; Walden, J.C. Fate of haem iron in the malaria parasite Plasmodium falciparum. Biochem. J., 2002, 365, (Pt 2), 343-347. (Pubitemid 36135306)
52. Rock, E.P.; Marsh, K.; Saul, A.J.; Wellems, T.E.; Taylor, D.W.; Maloy, W.L.; Howard, R.J. Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology., 1987, 95 ( Pt 2), 209-227. (Pubitemid 17144874)
53. Pandey, A.V.; Babbarwal, V.K.; Okoyeh, J.N.; Joshi, R.M.; Puri, S.K.; Singh, R.L.; Chauhan, V.S. Hemozoin formation in malaria: a two-step process involving histidine-rich proteins and lipids. Biochem. Biophys. Res. Commun., 2003, 308, (4), 736-743. (Pubitemid 36976524)
54. Slater, A.F.; Swiggard, W.J.; Orton, B.R.; Flitter, W.D.; Goldberg, D.E.; Cerami, A.; Henderson, G.B. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci .USA., 1991, 88, (2), 325-329. (Pubitemid 21915458)
55. Jani, D.; Nagarkatti, R.; Beatty, W.; Angel, R.; Slebodnick, C.; Andersen, J.; Kumar, S.; Rathore, D. HDP-a novel heme detoxification protein from the malaria parasite. PLoS. Pathog., 2008, 4, (4), e1000053.
56. Atamna, H.; Ginsburg, H. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J .Biol .Chem., 1995, 270, (42), 24876-24883.
57. Boyer, T.D.; Olsen, E. Role of glutathione S-transferases in heme transport. Biochem .Pharmacol., 1991, 42, (1), 188-190.
58. Harwaldt, P.; Rahlfs, S.; Becker, K. Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target. Biol. Chem., 2002, 383, (5), 821-830. (Pubitemid 34649901)
59. Kawazu, S.; Ikenoue, N.; Takemae, H.; Komaki-Yasuda, K.; Kano, S. Roles of 1-Cys peroxiredoxin in haem detoxification in the human malaria parasite Plasmodium falciparum. FEBS. J., 2005, 272, (7), 1784-1791. (Pubitemid 40516227)
60. Loria, P.; Miller, S.; Foley, M.; Tilley, L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem. J., 1999, 339 ( Pt 2), 363-370. (Pubitemid 29209967)
61. Nagababu, E.; Chrest, F.J.; Rifkind, J.M. Hydrogen-peroxide-induced heme degradation in red blood cells: the protective roles of catalase and glutathione peroxidase. Biochim. Biophys. Acta., 2003, 1620, (1-3), 211-217. (Pubitemid 36197913)
62. Alam, A.; Goyal, M.; Iqbal, M.S.; Bindu, S.; Dey, S.; Pal, C.; Maity, P.; Mascarenhas, N.M.; Ghoshal, N.; Bandyopadhyay, U. Cysteine-3 and cysteine-4 are essential for thioredoxin-like oxidoreductase and antioxidant activities of Plasmodium falciparum macrophage migration inhibitory factor. Free. Radic. Biol. Med., 2011, 50, 1659-1668.
63. Karisch, R.; Fernandez, M.; Taylor, P.; Virtanen, C.; St-Germain, J.R.; Jin, L.L.; Harris, I.S.; Mori, J.; Mak, T.W.; Senis, Y.A.; Ostman, A.; Moran, M.F.; Neel, B.G. Global proteomic assessment of the classical proteintyrosine phosphatome and "Redoxome". Cell, 2011, 146, (5), 826-840.
64. Heneberg, P.; Draberova, L.; Bambouskova, M.; Pompach, P.; Draber, P. Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts. J. Biol. Chem. 2010, 285 (17), 12787-12802.
65. Heneberg, P.; Draber, P. Regulation of Cys-based protein tyrosine phosphatases via reactive oxygen and nitrogen species in mast cells and basophils. Curr. Med. Chem. 2005, 12 (16), 1859-1871. (Pubitemid 41015183)
66. Heneberg, P. Finding the smoking gun: protein tyrosine phosphatases as tools and targets of unicellular microorganisms and viruses. Curr. Med. Chem., 2012, in press.
67. Sies, H. Glutathione and its role in cellular functions. Free. Radic .Biol. Med., 1999, 27, (9-10), 916-921. (Pubitemid 29507465)
68. Muller, S. Thioredoxin reductase and glutathione synthesis in Plasmodium falciparum. Redox. Rep., 2003, 8, (5), 251-255. (Pubitemid 38035582)
69. Atamna, H.; Pascarmona, G.; Ginsburg, H. Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites. Mol. Biochem. Parasitol., 1994, 67, (1), 79-89. (Pubitemid 24287313)
70. Atamna, H.; Ginsburg, H. The malaria parasite supplies glutathione to its host cell-investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum. Eur. J. Biochem., 1997, 250, (3), 670-679. (Pubitemid 28022483)
71. Vega-Rodriguez, J.; Franke-Fayard, B.; Dinglasan, R.R.; Janse, C.J.; Pastrana-Mena, R.; Waters, A.P.; Coppens, I.; Rodriguez-Orengo, J.F.; Srinivasan, P.; Jacobs-Lorena, M.; Serrano, A.E. The glutathione biosynthetic pathway of Plasmodium is essential for mosquito transmission. PLoS Pathog., 2009, 5, (2), e1000302.
72. Klokouzas, A.; Tiffert, T.; van Schalkwyk, D.; Wu, C.P.; van Veen, H.W.; Barrand, M.A.; Hladky, S.B. Plasmodium falciparum expresses a multidrug resistance-associated protein. Biochem. Biophys. Res .Commun., 2004, 321, (1), 197-201. (Pubitemid 39055624)
73. Raj, D.K.; Mu, J.; Jiang, H.; Kabat, J.; Singh, S.; Sullivan, M.; Fay, M.P.; McCutchan, T.F.; Su, X.Z. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J. Biol. Chem., 2009, 284, (12), 7687-7696.
74. Salinas, A.E.; Wong, M.G. Glutathione S-transferases-a review. Curr. Med. Chem., 1999, 6, (4), 279-309.
75. Rahlfs, S.; Nickel, C.; Deponte, M.; Schirmer, R.H.; Becker, K. Plasmodium falciparum thioredoxins and glutaredoxins as central players in redox metabolism. Redox Rep, 2003, 8, (5), 246-250. (Pubitemid 38035581)
76. Hiller, N.; Fritz-Wolf, K.; Deponte, M.; Wende, W.; Zimmermann, H.; Becker, K. Plasmodium falciparum glutathione S-transferase-structural and mechanistic studies on ligand binding and enzyme inhibition. Protein. Sci., 2006, 15, (2), 281-289. (Pubitemid 43145000)
77. Deponte, M.; Becker, K. Glutathione S-transferase from malarial parasites: structural and functional aspects. Methods. Enzymol., 2005, 401, 241-253. (Pubitemid 43052396)
78. Dubois, V.L.; Platel, D.F.; Pauly, G.; Tribouley-Duret, J. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp. Parasitol., 1995, 81, (1), 117-124.
79. Srivastava, P.; Puri, S.K.; Kamboj, K.K.; Pandey, V.C. Glutathione-Stransferase activity in malarial parasites. Trop. Med. Int .Health., 1999, 4, (4), 251-254.
80. Holmgren, A.; Johansson, C.; Berndt, C.; Lonn, M.E.; Hudemann, C.; Lillig, C.H. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem. Soc. Trans., 2005, 33, (Pt 6), 1375-1377. (Pubitemid 41779691)
81. Rahlfs, S.; Fischer, M.; Becker, K. Plasmodium falciparum possesses a classical glutaredoxin and a second, glutaredoxin-like protein with a PICOT homology domain. J. Biol. Chem., 2001, 276, (40), 37133-37140.
82. Becker, K.; Kanzok, S.M.; Iozef, R.; Fischer, M.; Schirmer, R.H.; Rahlfs, S. Plasmoredoxin, a novel redox-active protein unique for malarial parasites. Eur. J. Biochem., 2003, 270, (6), 1057-1064. (Pubitemid 36384440)
83. Buchholz, K.; Rahlfs, S.; Schirmer, R.H.; Becker, K.; Matuschewski, K. Depletion of Plasmodium berghei plasmoredoxin reveals a non-essential role for life cycle progression of the malaria parasite. PLoS One., 2008, 3, (6), e2474.
84. Belli, G.; Polaina, J.; Tamarit, J.; De La Torre, M.A.; Rodriguez-Manzaneque, M.T.; Ros, J.; Herrero, E. Structure-function analysis of yeast Grx5 monothiol glutaredoxin defines essential amino acids for the function of the protein. J. Biol. Chem., 2002, 277, (40), 37590-37596.
85. Kehr, S.; Sturm, N.; Rahlfs, S.; Przyborski, J.M.; Becker, K. Compartmentation of redox metabolism in malaria parasites. PLoS Pathog., 2010, 6, (12), e1001242.
86. Nickel, C.; Trujillo, M.; Rahlfs, S.; Deponte, M.; Radi, R.; Becker, K. Plasmodium falciparum 2-Cys peroxiredoxin reacts with plasmoredoxin and peroxynitrite. Biol. Chem., 2005, 386, (11), 1129-1136. (Pubitemid 41705367)
87. Boucher, I.W.; Brzozowski, A.M.; Brannigan, J.A.; Schnick, C.; Smith, D.J.; Kyes, S.A.; Wilkinson, A.J. The crystal structure of superoxide dismutase from Plasmodium falciparum. BMC. Struct. Biol., 2006, 6, 20.
88. de Koning-Ward, T.F.; Gilson, P.R.; Boddey, J.A.; Rug, M.; Smith, B.J.; Papenfuss, A.T.; Sanders, P.R.; Lundie, R.J.; Maier, A.G.; Cowman, A.F.; Crabb, B.S. A newly discovered protein export machine in malaria parasites. Nature, 2009, 459, (7249), 945-949.
89. Sienkiewicz, N.; Daher, W.; Dive, D.; Wrenger, C.; Viscogliosi, E.; Wintjens, R.; Jouin, H.; Capron, M.; Muller, S.; Khalife, J. Identification of a mitochondrial superoxide dismutase with an unusual targeting sequence in Plasmodium falciparum. Mol. Biochem. Parasitol., 2004, 137, (1), 121-132. (Pubitemid 38987949)
90. Williams, C.H. Lipoamide dehydrogenase, glutathione reductase, thioredoxin reductase and mercuric ion reductase-a family of flavoenzyme transhydrogenases. In: Chemistry and Biochemistry of Flavoenzymes, 1992, III, Müller, F. (ed.). Boca Raton, FL: CRC Press, pp. 121-211.
91. Sarma, G.N.; Savvides, S.N.; Becker, K.; Schirmer, M.; Schirmer, R.H.; Karplus, P.A. Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J. Mol. Biol., 2003, 328, (4), 893-907. (Pubitemid 36506894)
92. Gilberger, T.W.; Bergmann, B.; Walter, R.D.; Muller, S. The role of the Cterminus for catalysis of the large thioredoxin reductase from Plasmodium falciparum. FEBS. Lett., 1998, 425, (3), 407-410. (Pubitemid 28178841)
93. Wang, P.F.; Arscott, L.D.; Gilberger, T.W.; Muller, S.; Williams, C.H. Jr. Thioredoxin reductase from Plasmodium falciparum: evidence for interaction between the C-terminal cysteine residues and the active site disulfide-dithiol. Biochemistry, 1999, 38, (10), 3187-3196.
94. Krnajski, Z.; Gilberger, T.W.; Walter, R.D.; Cowman, A.F.; Muller, S. Thioredoxin reductase is essential for the survival of Plasmodium falciparum erythrocytic stages. J. Biol. Chem., 2002, 277, (29), 25970-25975. (Pubitemid 34967078)
95. Buchholz, K.; Putrianti, E.D.; Rahlfs, S.; Schirmer, R.H.; Becker, K.; Matuschewski, K. Molecular genetics evidence for the in vivo roles of the two major NADPH-dependent disulfide reductases in the malaria parasite. J. Biol. Chem., 2010, 285, (48), 37388-37395.
96. Sztajer, H.; Gamain, B.; Aumann, K.D.; Slomianny, C.; Becker, K.; Brigelius-Flohe, R.; Flohe, L. The putative glutathione peroxidase gene of Plasmodium falciparum codes for a thioredoxin peroxidase. J .Biol. Chem., 2001, 276, (10), 7397-7403.
97. Kawazu, S.; Komaki-Yasuda, K.; Oku, H.; Kano, S. Peroxiredoxins in malaria parasites: parasitologic aspects. Parasitol. Int., 2008, 57, (1), 1-7. (Pubitemid 350116684)
98. Andricopulo, A.D.; Akoachere, M.B.; Krogh, R.; Nickel, C.; McLeish, M.J.; Kenyon, G.L.; Arscott, L.D.; Williams, C.H. Jr.; Davioud-Charvet, E.; Becker, K. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg. Med. Chem. Lett., 2006, 16, (8), 2283-2292. (Pubitemid 43351095)
99. Richard, D.; Bartfai, R.; Volz, J.; Ralph, S.A.; Muller, S.; Stunnenberg, H.G.; Cowman, A.F. A genome-wide chromatin-associated nuclear peroxiredoxin from the malaria parasite Plasmodium falciparum. J. Biol. Chem., 2011, 286, (13), 11746-11755.
100. Rhee, S.G.; Chae, H.Z.; Kim, K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free. Radic. Biol. Med., 2005, 38, (12), 1543-1552. (Pubitemid 40726061)
101. Sarma, G.N.; Nickel, C.; Rahlfs, S.; Fischer, M.; Becker, K.; Karplus, P.A. Crystal structure of a novel Plasmodium falciparum 1-Cys peroxiredoxin. J. Mol. Biol., 2005, 346, (4), 1021-1034. (Pubitemid 40215527)
102. Richard, D.; Bartfai, R.; Volz, J.; Ralph, S.A.; Muller, S.; Stunnenberg, H.G.; Cowman, A.F. A genome-wide chromatin-associated nuclear peroxiredoxin from the malaria parasite Plasmodium falciparum. J. Biol. Chem., 286, (13), 11746-11755.
103. Roth, E.F. Jr.; Raventos-Suarez, C.; Perkins, M.; Nagel, R.L. Glutathione stability and oxidative stress in P. falciparum infection in vitro: responses of normal and G6PD deficient cells. Biochem. Biophys. Res. Commun., 1982, 109, (2), 355-362. (Pubitemid 13119323)
104. Crooke, A.; Diez, A.; Mason, P.J.; Bautista, J.M. Transient silencing of Plasmodium falciparum bifunctional glucose-6-phosphate dehydrogenase-6- phosphogluconolactonase. FEBS. J., 2006, 273, (7), 1537-1546. (Pubitemid 44029116)
105. Aparicio, I.M.; Marin-Menendez, A.; Bell, A.; Engel, P.C. Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors-a possible new antimalarial target. Mol. Biochem. Parasitol., 2010, 172, (2), 152-155.
106. Werner, C.; Stubbs, M.T.; Krauth-Siegel, R.L.; Klebe, G. The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs. J. Mol. Biol., 2005, 349, (3), 597-607. (Pubitemid 40724568)
107. Dalle-Donne, I.; Rossi, R.; Colombo, G.; Giustarini, D.; Milzani, A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends. Biochem. Sci., 2009, 34, (2), 85-96.
108. Gallogly, M.M.; Mieyal, J.J. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol., 2007, 7, (4), 381-391. (Pubitemid 47304000)
109. Ghezzi, P. Oxidoreduction of protein thiols in redox regulation. Biochem. Soc. Trans., 2005, 33, (Pt 6), 1378-1381. (Pubitemid 41779692)
110. Zaffagnini, M.; Michelet, L.; Marchand, C.; Sparla, F.; Decottignies, P.; Le Marechal, P.; Miginiac-Maslow, M.; Noctor, G.; Trost, P.; Lemaire, S.D. The thioredoxin-independent isoform of chloroplastic glyceraldehyde-3-phosphate dehydrogenase is selectively regulated by glutathionylation. FEBS. J., 2007, 274, (1), 212-226. (Pubitemid 44952910)
111. Kehr, S.; Jortzik, E.; Delahunty, C.; Yates, J.R.; Rahlfs, S.; Becker, K. Protein S-Glutathionylation in Malaria Parasites. Antioxid. Redox. Signal., 2011.
112. Clarebout, G.; Slomianny, C.; Delcourt, P.; Leu, B.; Masset, A.; Camus, D.; Dive, D. Status of Plasmodium falciparum towards catalase. Br. J. Haematol., 1998, 103, (1), 52-59. (Pubitemid 28470799)
113. Koncarevic, S.; Rohrbach, P.; Deponte, M.; Krohne, G.; Prieto, J.H.; Yates, J. 3rd; Rahlfs, S.; Becker, K. The malarial parasite Plasmodium falciparum imports the human protein peroxiredoxin 2 for peroxide detoxification. Proc. Natl. Acad. Sci. USA., 2009, 106, (32), 13323-13328.
114. Fairfield, A.S.; Eaton, J.W.; Meshnick, S.R. Superoxide dismutase and catalase in the murine malaria, Plasmodium berghei: content and subcellular distribution. Arch. Biochem. Biophys., 1986, 250, (2), 526-529.
115. Toler, S. The plasmodial apicoplast was retained under evolutionary selective pressure to assuage blood stage oxidative stress. Med. Hypotheses., 2005, 65, (4), 683-690. (Pubitemid 41021849)
116. Bilska, A.; Wlodek, L. Lipoic acid-the drug of the future? Pharmacol. Rep., 2005, 57, (5), 570-577.
117. Gunther, S.; Matuschewski, K.; Muller, S. Knockout studies reveal an important role of Plasmodium lipoic acid protein ligase A1 for asexual blood stage parasite survival. PLoS One, 2009, 4, (5), e5510.
118. Ralph, S.A.; van Dooren, G.G.; Waller, R.F.; Crawford, M.J.; Fraunholz, M.J.; Foth, B.J.; Tonkin, C.J.; Roos, D.S.; McFadden, G.I. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol., 2004, 2, (3), 203-216. (Pubitemid 39490083)
119. Balconi, E.; Pennati, A.; Crobu, D.; Pandini, V.; Cerutti, R.; Zanetti, G.; Aliverti, A. The ferredoxin-NADP+ reductase/ferredoxin electron transfer system of Plasmodium falciparum. FEBS. J., 2009, 276, (14), 3825-3836.
120. Kawahara, K.; Mogi, T.; Tanaka, T.Q.; Hata, M.; Miyoshi, H.; Kita, K. Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii. J. Biochem., 2009, 145, (2), 229-237.
121. Painter, H.J.; Morrisey, J.M.; Mather, M.W.; Vaidya, A.B. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature, 2007, 446, (7131), 88-91. (Pubitemid 46348043)
122. Wrenger, C.; Muller, S. The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways. Mol. Microbiol., 2004, 53, (1), 103-113. (Pubitemid 38901383)
123. Tu, B.P.; Weissman, J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell. Biol., 2004, 164, (3), 341-346. (Pubitemid 38174761)
124. Shimizu, Y.; Hendershot, L.M. Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid. Redox .Signal., 2009, 11, (9), 2317-2331.
125. Mahajan, B.; Noiva, R.; Yadava, A.; Zheng, H.; Majam, V.; Mohan, K.V.; Moch, J.K.; Haynes, J.D.; Nakhasi, H.; Kumar, S. Protein disulfide isomerase assisted protein folding in malaria parasites. Int J Parasitol, 2006, 36, (9), 1037-1048. (Pubitemid 44107935)
126. Mouray, E.; Moutiez, M.; Girault, S.; Sergheraert, C.; Florent, I.; Grellier, P. Biochemical properties and cellular localization of Plasmodium falciparum protein disulfide isomerase. Biochimie, 2007, 89, (3), 337-346. (Pubitemid 46442764)
127. Chakravarthi, S.; Jessop, C.E.; Bulleid, N.J. The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO. Rep., 2006, 7, (3), 271-275.
128. Meierjohann, S.; Walter, R.D.; Muller, S. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem. J., 2002, 368, (Pt 3), 761-768. (Pubitemid 36042677)
129. Zhang, Y.A.; Hempelmann, E.; Schirmer, R.H. Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem. Pharmacol., 1988, 37, (5), 855-860. (Pubitemid 18058456)
130. Grellier, P.; Maroziene, A.; Nivinskas, H.; Sarlauskas, J.; Aliverti, A.; Cenas, N. Antiplasmodial activity of quinones: roles of aziridinyl substituents and the inhibition of Plasmodium falciparum glutathione reductase. Arch. Biochem. Biophys., 2010, 494, (1), 32-39.
131. Becker, K.; Christopherson, R.I.; Cowden, W.B.; Hunt, N.H.; Schirmer, R.H. Flavin analogs with antimalarial activity as glutathione reductase inhibitors. Biochem. Pharmacol., 1990, 39, (1), 59-65. (Pubitemid 20027970)
132. Schirmer, R.H.; Coulibaly, B.; Stich, A.; Scheiwein, M.; Merkle, H.; Eubel, J.; Becker, K.; Becher, H.; Muller, O.; Zich, T.; Schiek, W.; Kouyate, B. Methylene blue as an antimalarial agent. Redox. Rep., 2003, 8, (5), 272-275. (Pubitemid 38035586)
133. Kirsch, P. Schönleben-Janas. A. Schirmer. H. R. Synthesis and characterization of water-soluble and photolabile 10-arylisoalloxazines: Tools for studying the mechanism of action of flavin-type antimalarials. Eur. J .org. chem., , 1995, 1995, (7), 1275-1281.
134. Savvides, S.N.; Scheiwein, M.; Bohme, C.C.; Arteel, G.E.; Karplus, P.A.; Becker, K.; Schirmer, R.H. Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite. J .Biol. Chem., 2002, 277, (4), 2779-2784. (Pubitemid 34953308)
135. Krauth-Siegel, R.L.; Bauer, H.; Schirmer, R.H. Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angew. Chem. Int. Ed. Engl., 2005, 44, (5), 690-715. (Pubitemid 40203977)
136. Soh, P.N.; Witkowski, B.; Olagnier, D.; Nicolau, M.L.; Garcia-Alvarez, M.C.; Berry, A.; Benoit-Vical, F. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob. Agents. Chemother., 2009, 53, (3), 1100-1106.
137. Sturm, N.; Hu, Y.; Zimmermann, H.; Fritz-Wolf, K.; Wittlin, S.; Rahlfs, S.; Becker, K. Compounds structurally related to ellagic acid show improved antiplasmodial activity. Antimicrob. Agents. Chemother., 2009, 53, (2), 622-630.
138. Massimine, K.M.; McIntosh, M.T.; Doan, L.T.; Atreya, C.E.; Gromer, S.; Sirawaraporn, W.; Elliott, D.A.; Joiner, K.A.; Schirmer, R.H.; Anderson, K.S. Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum. Antimicrob. Agents. Chemother., 2006, 50, (9), 3132-3141. (Pubitemid 44403775)
139. Akoachere, M.; Buchholz, K.; Fischer, E.; Burhenne, J.; Haefeli, W.E.; Schirmer, R.H.; Becker, K. In vitro assessment of methylene blue on chloroquine-sensitive and-resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob. Agents. Chemother., 2005, 49, (11), 4592-4597. (Pubitemid 41552588)
140. Buchholz, K.; Schirmer, R.H.; Eubel, J.K.; Akoachere, M.B.; Dandekar, T.; Becker, K.; Gromer, S. Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum. Antimicrob. Agents. Chemother., 2008, 52, (1), 183-191.
141. Farber, P.M.; Arscott, L.D.; Williams, C.H. Jr.; Becker, K.; Schirmer, R.H. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS. Lett., 1998, 422, (3), 311-314. (Pubitemid 28075485)
142. Morin, C.; Besset, T.; Moutet, J.C.; Fayolle, M.; Bruckner, M.; Limosin, D.; Becker, K.; Davioud-Charvet, E. The aza-analogues of 1,4-naphthoquinones are potent substrates and inhibitors of plasmodial thioredoxin and glutathione reductases and of human erythrocyte glutathione reductase. Org. Biomol. Chem., 2008, 6, (15), 2731-2742. (Pubitemid 352027703)
143. Davioud-Charvet, E.; Delarue, S.; Biot, C.; Schwobel, B.; Boehme, C.C.; Mussigbrodt, A.; Maes, L.; Sergheraert, C.; Grellier, P.; Schirmer, R.H.; Becker, K. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J. Med. Chem., 2001, 44, (24), 4268-4276. (Pubitemid 33095332)
144. Biot, C.; Bauer, H.; Schirmer, R.H.; Davioud-Charvet, E. 5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials. J. Med .Chem., 2004, 47, (24), 5972-5983. (Pubitemid 39507339)
145. Biot, C.; Dessolin, J.; Grellier, P.; Davioud-Charvet, E. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Redox. Rep., 2003, 8, (5), 280-283. (Pubitemid 38035588)
146. Friebolin, W.; Jannack, B.; Wenzel, N.; Furrer, J.; Oeser, T.; Sanchez, C.P.; Lanzer, M.; Yardley, V.; Becker, K.; Davioud-Charvet, E. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. J. Med. Chem., 2008, 51, (5), 1260-1277. (Pubitemid 351480388)
147. Muller, T.; Johann, L.; Jannack, B.; Bruckner, M.; Lanfranchi, D.A.; Bauer, H.; Sanchez, C.; Yardley, V.; Deregnaucourt, C.; Schrevel, J.; Lanzer, M.; Schirmer, R.H.; Davioud-Charvet, E. Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones-a new strategy to combat malarial parasites. J. Am. Chem. Soc., 2011, 133, (30), 11557-11571.
148. Kasozi, D.M.; Gromer, S.; Adler, H.; Zocher, K.; Rahlfs, S.; Wittlin, S.; Fritz-Wolf, K.; Schirmer, R.H.; Becker, K. The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue. Redox. Rep., 2011, 16, (4), 154-165.
149. Davioud-Charvet, E.; McLeish, M.J.; Veine, D.M.; Giegel, D.; Arscott, L.D.; Andricopulo, A.D.; Becker, K.; Muller, S.; Schirmer, R.H.; Williams, C.H. Jr.; Kenyon, G.L. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity. Biochemistry, 2003, 42, (45), 13319-13330. (Pubitemid 37420684)
150. Sannella, A.R.; Casini, A.; Gabbiani, C.; Messori, L.; Bilia, A.R.; Vincieri, F.F.; Majori, G.; Severini, C. New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications. FEBS. Lett., 2008, 582, (6), 844-847.
151. Li, R.; Kenyon, G.L.; Cohen, F.E.; Chen, X.; Gong, B.; Dominguez, J.N.; Davidson, E.; Kurzban, G.; Miller, R.E.; Nuzum, E.O.; Rosenthal, J.P. In vitro antimalarial activity of chalcones and their derivatives. J. Med. Chem., 1995, 38, (26), 5031-5037. (Pubitemid 26012258)
152. Perbandt, M.; Burmeister, C.; Walter, R.D.; Betzel, C.; Liebau, E. Native and inhibited structure of a Mu class-related glutathione S-transferase from Plasmodium falciparum. J. Biol .Chem., 2004, 279, (2), 1336-1342. (Pubitemid 38082659)
153. Ahmad, R.; Srivastava, A.K. Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits. Parasitol. Res., 2008, 102, (4), 805-807.
154. Mangoyi, R.; Hayeshi, R.; Ngadjui, B.; Ngandeu, F.; Bezabih, M.; Abegaz, B.; Razafimahefa, S.; Rasoanaivo, P.; Mukanganyama, S. Glutathione transferase from Plasmodium falciparum-interaction with malagashanine and selected plant natural products. J. Enzyme. Inhib. Med. Chem., 2010, 25, (6), 854-862.
155. Ahmad, R.; Srivastava, A.K.; Tripathi, R.P.; Batra, S.; Walter, R.D. Synthesis and biological evaluation of potential modulators of malarial glutathione-S-transferase(s). J. Enzyme. Inhib. Med. Chem., 2007, 22, (3), 327-342. (Pubitemid 47225726)
156. Royer, R.E.; Deck, L.M.; Campos, N.M.; Hunsaker, L.A.; Vander Jagt, D.L. Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. J .Med .Chem., 1986, 29, (9), 1799-1801. (Pubitemid 16018218)
157. Foley, M.; Tilley, L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther., 1998, 79, (1), 55-87. (Pubitemid 28318262)
158. Pandey, A.V.; Tekwani, B.L. Depolymerization of malarial hemozoin: a novel reaction initiated by blood schizontocidal antimalarials. FEBS. Lett., 1997, 402, (2-3), 236-240. (Pubitemid 27078265)
159. Hawley, S.R.; Bray, P.G.; O'Neill, P.M.; Naisbitt, D.J.; Park, B.K.; Ward, S.A. Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Antimicrob. Agents. Chemother., 1996, 40, (10), 2345-2349. (Pubitemid 26328044)
160. O'Neill, P.M.; Willock, D.J.; Hawley, S.R.; Bray, P.G.; Storr, R.C.; Ward, S.A.; Park, B.K. Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues. J. Med. Chem., 1997, 40, (4), 437-448. (Pubitemid 27080022)
161. O'Neill, P.M.; Mukhtar, A.; Stocks, P.A.; Randle, L.E.; Hindley, S.; Ward, S.A.; Storr, R.C.; Bickley, J.F.; O'Neil, I.A.; Maggs, J.L.; Hughes, R.H.; Winstanley, P.A.; Bray, P.G.; Park, B.K. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. J .Med .Chem., 2003, 46, (23), 4933-4945. (Pubitemid 37352033)
162. Paunescu, E.; Susplugas, S.; Boll, E.; Varga, R.; Mouray, E.; Grosu, I.; Grellier, P.; Melnyk, P. Replacement of the 4'-hydroxy group of amodiaquine and amopyroquine by aromatic and aliphatic substituents: synthesis and antimalarial activity. ChemMedChem, 2009, 4, (4), 549-561.
163. Chang, C.; Lin-Hua, T.; Jantanavivat, C. Studies on a new antimalarial compound: pyronaridine. Trans. R. Soc .Trop. Med. Hyg., 1992, 86, (1), 7-10.
164. Sparatore, A.; Basilico, N.; Casagrande, M.; Parapini, S.; Taramelli, D.; Brun, R.; Wittlin, S.; Sparatore, F. Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinoline. Bioorg. Med .Chem. Lett., 2008, 18, (13), 3737-3740.
165. Sunduru, N.; Srivastava, K.; Rajakumar, S.; Puri, S.K.; Saxena, J.K.; Chauhan, P.M. Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials. Bioorg. Med .Chem. Lett., 2009, 19, (9), 2570-2573.
166. Sunduru, N.; Nishi; Palne, S.; Chauhan, P.M.; Gupta, S. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines. Eur. J .Med. Chem., 2009, 44, (6), 2473-2481.
167. Raynes, K. Bisquinoline antimalarials: their role in malaria chemotherapy. Int. J. Parasitol., 1999, 29, (3), 367-379. (Pubitemid 29171697)
168. Chen, L. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chin. Med .J (Engl)., 1991, 104, (2), 161-163.
169. Davis, T.M.; Hung, T.Y.; Sim, I.K.; Karunajeewa, H.A.; Ilett, K.F. Piperaquine: a resurgent antimalarial drug. Drugs, 2005, 65, (1), 75-87. (Pubitemid 40143802)
170. Dorn, A.; Vippagunta, S.R.; Matile, H.; Jaquet, C.; Vennerstrom, J.L.; Ridley, R.G. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol., 1998, 55, (6), 727-736. (Pubitemid 28319636)
171. Arancibia, R.; Dubar, F.; Pradines, B.; Forfar, I.; Dive, D.; Klahn, A.H.; Biot, C. Synthesis and antimalarial activities of rhenium bioorganometallics based on the 4-aminoquinoline structure. Bioorg. Med .Chem., 2010, 18, (22), 8085-8091.
172. Angerhofer, C.K.; Pezzuto, J.M.; Konig, G.M.; Wright, A.D.; Sticher, O. Antimalarial activity of sesquiterpenes from the marine sponge Acanthella klethra. J. Nat. Prod., 1992, 55, (12), 1787-1789. (Pubitemid 23023270)
173. Wright, A.D.; Wang, H.; Gurrath, M.; Konig, G.M.; Kocak, G.; Neumann, G.; Loria, P.; Foley, M.; Tilley, L. Inhibition of heme detoxification processes underlies the antimalarial activity of terpene isonitrile compounds from marine sponges. J. Med. Chem., 2001, 44, (6), 873-885. (Pubitemid 32861612)
174. Schwarz, O. Brun, R. Bats, J.W. Schmalz, H.-G., Synthesis and biological evaluation of new antimalarial isonitriles related to marine diterpenoids. Tetrahedron. Letters., 2002, 43, 1009-1013.
175. Singh, C.; Srivastav, N.C.; Puri, S.K. In vivo active antimalarial isonitriles. Bioorg. Med. Chem. Lett., 2002, 12, (17), 2277-2279. (Pubitemid 34879848)
176. White, R.D.; Keaney, G.F.; Slown, C.D.; Wood, J.L. Total synthesis of ( +-)-kalihinol C. Org. Lett., 2004, 6, (7), 1123-1126.
177. Ignatushchenko, M.V.; Winter, R.W.; Bachinger, H.P.; Hinrichs, D.J.; Riscoe, M.K. Xanthones as antimalarial agents; studies of a possible mode of action. FEBS. Lett., 1997, 409, (1), 67-73. (Pubitemid 27248569)
178. Fotie, J.; Nkengfack, A.E.; Rukunga, G.; Tolo, F.; Peter, M.G.; Heydenreich, M.; Fomum, Z.T. In vivo antimalarial activity of some oxygenated xanthones. Ann. Trop. Med .Parasitol., 2003, 97, (7), 683-688. (Pubitemid 37468133)
179. Hay, A.E.; Helesbeux, J.J.; Duval, O.; Labaied, M.; Grellier, P.; Richomme, P. Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii. Life .Sci., 2004, 75, (25), 3077-3085. (Pubitemid 39330589)
180. Kelly, J.X.; Winter, R.; Peyton, D.H.; Hinrichs, D.J.; Riscoe, M. Optimization of xanthones for antimalarial activity: the 3,6-bis- omegadiethylaminoalkoxyxanthone series. Antimicrob. Agents. Chemother., 2002, 46, (1), 144-150. (Pubitemid 34031616)
181. Chong, C.R.; Sullivan, D.J. Jr. Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. Biochem. Pharmacol., 2003, 66, (11), 2201-2212. (Pubitemid 37377865)
182. Huy, N.T.; Kamei, K.; Yamamoto, T.; Kondo, Y.; Kanaori, K.; Takano, R.; Tajima, K.; Hara, S. Clotrimazole binds to heme and enhances hemedependent hemolysis: proposed antimalarial mechanism of clotrimazole. J. Biol. Chem., 2002, 277, (6), 4152-4158. (Pubitemid 34968676)
183. Huy, N.T.; Kamei, K.; Kondo, Y.; Serada, S.; Kanaori, K.; Takano, R.; Tajima, K.; Hara, S. Effect of antifungal azoles on the heme detoxification system of malarial parasite. J. Biochem., 2002, 131, (3), 437-444. (Pubitemid 34292835)
184. Trivedi, V.; Chand, P.; Srivastava, K.; Puri, S.K.; Maulik, P.R.; Bandyopadhyay, U. Clotrimazole inhibits hemoperoxidase of Plasmodium falciparum and induces oxidative stress. Proposed antimalarial mechanism of clotrimazole. J. Biol. Chem., 2005, 280, (50), 41129-41136. (Pubitemid 41832165)
185. Gemma, S.; Campiani, G.; Butini, S.; Kukreja, G.; Joshi, B.P.; Persico, M.; Catalanotti, B.; Novellino, E.; Fattorusso, E.; Nacci, V.; Savini, L.; Taramelli, D.; Basilico, N.; Morace, G.; Yardley, V.; Fattorusso, C. Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore. J. Med. Chem., 2007, 50, (4), 595-598. (Pubitemid 46332972)
186. Gemma, S.; Campiani, G.; Butini, S.; Kukreja, G.; Coccone, S.S.; Joshi, B.P.; Persico, M.; Nacci, V.; Fiorini, I.; Novellino, E.; Fattorusso, E.; Taglialatela-Scafati, O.; Savini, L.; Taramelli, D.; Basilico, N.; Parapini, S.; Morace, G.; Yardley, V.; Croft, S.; Coletta, M.; Marini, S.; Fattorusso, C. Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies. J. Med. Chem., 2008, 51, (5), 1278-1294. (Pubitemid 351480389)
187. Gemma, S.; Campiani, G.; Butini, S.; Joshi, B.P.; Kukreja, G.; Coccone, S.S.; Bernetti, M.; Persico, M.; Nacci, V.; Fiorini, I.; Novellino, E.; Taramelli, D.; Basilico, N.; Parapini, S.; Yardley, V.; Croft, S.; Keller-Maerki, S.; Rottmann, M.; Brun, R.; Coletta, M.; Marini, S.; Guiso, G.; Caccia, S.; Fattorusso, C. Combining 4-aminoquinoline-and clotrimazolebased pharmacophores toward innovative and potent hybrid antimalarials. J. Med. Chem., 2009, 52, (2), 502-513.
188. Atamna, H.; Krugliak, M.; Shalmiev, G.; Deharo, E.; Pescarmona, G.; Ginsburg, H. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochem. Pharmacol., 1996, 51, (5), 693-700. (Pubitemid 26080142)
189. Vennerstrom, J.L.; Makler, M.T.; Angerhofer, C.K.; Williams, J.A. Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob. Agents. Chemother., 1995, 39, (12), 2671-2677.
190. Kalkanidis, M.; Klonis, N.; Tilley, L.; Deady, L.W. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin. Biochem. Pharmacol., 2002, 63, (5), 833-842. (Pubitemid 34242995)
191. Zoungrana, A.; Coulibaly, B.; Sie, A.; Walter-Sack, I.; Mockenhaupt, F.P.; Kouyate, B.; Schirmer, R.H.; Klose, C.; Mansmann, U.; Meissner, P.; Muller, O. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One, 2008, 3, (2), e1630.
192. Coulibaly, B.; Zoungrana, A.; Mockenhaupt, F.P.; Schirmer, R.H.; Klose, C.; Mansmann, U.; Meissner, P.E.; Muller, O. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One, 2009, 4, (5), e5318.
193. Martiney, J.A.; Cerami, A.; Slater, A.F. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait. Mol. Med., 1996, 2, (2), 236-246. (Pubitemid 26421993)
194. Basilico, N.; Monti, D.; Olliaro, P.; Taramelli, D. Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation. FEBS Lett., 1997, 409, (2), 297-299. (Pubitemid 27273896)
195. Cole, K.A.; Ziegler, J.; Evans, C.A.; Wright, D.W. Metalloporphyrins inhibit beta-hematin (hemozoin) formation. J. Inorg. Biochem., 2000, 78, (2), 109-115. (Pubitemid 30407050)
196. Begum, K.; Kim, H.S.; Kumar, V.; Stojiljkovic, I.; Wataya, Y. In vitro antimalarial activity of metalloporphyrins against Plasmodium falciparum. Parasitol. Res., 2003, 90, (3), 221-224. (Pubitemid 36819142)
197. Kumar, S.; Guha, M.; Choubey, V.; Maity, P.; Srivastava, K.; Puri, S.K.; Bandyopadhyay, U. Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species. Free. Radic. Biol. Med., 2008, 44, (4), 602-613.
198. Goldberg, D.E.; Sharma, V.; Oksman, A.; Gluzman, I.Y.; Wellems, T.E.; Piwnica-Worms, D. Probing the chloroquine resistance locus of Plasmodium falciparum with a novel class of multidentate metal(III) coordination complexes. J. Biol. Chem., 1997, 272, (10), 6567-6572. (Pubitemid 27118139)
199. Van Miert, S.; Hostyn, S.; Maes, B.U.; Cimanga, K.; Brun, R.; Kaiser, M.; Matyus, P.; Dommisse, R.; Lemiere, G.; Vlietinck, A.; Pieters, L. Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound. J. Nat. Prod., 2005, 68, (5), 674-677. (Pubitemid 40825273)
200. El Sayed, I.; Van der Veken, P.; Steert, K.; Dhooghe, L.; Hostyn, S.; Van Baelen, G.; Lemiere, G.; Maes, B.U.; Cos, P.; Maes, L.; Joossens, J.; Haemers, A.; Pieters, L.; Augustyns, K. Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives. J .Med .Chem., 2009, 52, (9), 2979-2988.
201. Valdes, A.F. Acridine and acridinones: old and new structures with antimalarial activity. Open. Med. Chem. J., 2011, 5, 11-20.
202. Bauer, H.; Fritz-Wolf, K.; Winzer, A.; Kuhner, S.; Little, S.; Yardley, V.; Vezin, H.; Palfey, B.; Schirmer, R.H.; Davioud-Charvet, E. A fluoro analogue of the menadione derivative 6-[2'-(3'-methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme. J .Am. Chem. Soc., 2006, 128, (33), 10784-10794. (Pubitemid 44277767)
203. Klonis, N.; Crespo-Ortiz, M.P.; Bottova, I.; Abu-Bakar, N.; Kenny, S.; Rosenthal, P.J.; Tilley, L. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc. Natl. Acad. Sci. USA, 2011, 108, (28), 11405-11410.
204. Haynes, R.K.; Chan, W.C.; Wong, H.N.; Li, K.Y.; Wu, W.K.; Fan, K.M.; Sung, H.H.; Williams, I.D.; Prosperi, D.; Melato, S.; Coghi, P.; Monti, D. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action. ChemMedChem, 2010, 5, (8), 1282-1299.
205. Haynes, R.K.; Cheu, K.W.; Li, K.Y.; Tang, M.M.; Wong, H.N.; Chen, M.J.; Guo, Z.F.; Guo, Z.H.; Coghi, P.; Monti, D. A partial convergence in action of methylene blue and artemisinins: antagonism with chloroquine, a reversal with verapamil, and an insight into the antimalarial activity of chloroquine. ChemMedChem, 2011, 6, (9), 1603-1615.
206. Haynes, R.K.; Cheu, K.W.; Tang, M.M.; Chen, M.J.; Guo, Z.F.; Guo, Z.H.; Coghi, P.; Monti, D. Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: flavin reductase and the cofactor model exemplified. ChemMedChem, 2011, 6, (2), 279-291.
207. Legorreta-Herrera, M.; Retana-Ugalde, R.; Ventura-Gallegos, J.L.; Narvaez, V. Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XLinfected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug? Exp. Parasitol., 2010, 126, (3), 381-388.
208. Cui, L.; Miao, J. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob. Agents .Chemother., 2007, 51, (2), 488-494. (Pubitemid 46185265)